Ofatumumab
Get a Quick Quote Now
Select Packaging
Product Description
Product
Ofatumumab
CAS
679818-59-8
Formula
C6480H10022N1742O2020S44
Synonym
Arzerra, Arzerra Injection, GSK 1841157, GSK1841157, HSDB 8170, HuMax-CD20, HuMax-CD20, 2F2, Immunoglobulin G1, anti-(human CD20 (antigen))(human monoclonal HuMax-CD20 heavy chain), disulfide with human monoclonal HuMax-CD20 kappa-chain, dimer, Ofatumumab, UNII-M95KG522R0
Typical Product Specifications
Molecular weight
146100.0 Da
Assay/Purity
Typically NLT 98%
Notes
Ofatumumab is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
Ofatumumab
Product Description
Product
Ofatumumab
CAS
679818-59-8
Formula
C6480H10022N1742O2020S44
Synonym
Arzerra, Arzerra Injection, GSK 1841157, GSK1841157, HSDB 8170, HuMax-CD20, HuMax-CD20, 2F2, Immunoglobulin G1, anti-(human CD20 (antigen))(human monoclonal HuMax-CD20 heavy chain), disulfide with human monoclonal HuMax-CD20 kappa-chain, dimer, Ofatumumab, UNII-M95KG522R0
Typical Product Specifications
Molecular weight
146100.0 Da
Assay/Purity
Typically NLT 98%
Notes
Ofatumumab is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
